» Articles » PMID: 9579575

Increased Invasiveness of MUC1 and CDNA-transfected Human Gastric Cancer MKN74 Cells

Overview
Journal Int J Cancer
Specialty Oncology
Date 1998 May 14
PMID 9579575
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

MUC1 mucin is an anti-adhesion molecule expressed in a wide variety of tumors. To examine whether MUC1 mucin is involved in tumor invasion, we have prepared MUC1 transfectants using the human gastric cancer cell line MKN74 and performed an in vivo tumor assay by transplanting these into nude mice. Tumor weight at 71 days after s.c. injection of transfectants was measured, showing that the in vivo growth of MUC1 transfectants was increased compared to that of mock transfectants. Furthermore, MUC1-transfectant tumors invaded into the muscle layer, whereas mock-transfectant tumors did not. In vitro invasion, adhesion to extracellular matrix components and phagokinetic track motility were then evaluated to analyze the mechanisms for the in vivo invasiveness of the transfectants. MUC1 transfectants exhibited an increased in vitro invasiveness, decreased binding to laminin, fibronectin, type I collogen and type IV collagen and increased motility. These effects of MUC1 mucin over-expression in MKN74 cells were abolished by the treatment of transfectants with an inhibitor of O-glycan biosynthesis, benzyl-alpha-GalNAc. Our data suggest that MUC1 mucin could be related to the increased invasive ability of MKN74 cells, whereas O-glycan might play an essential role.

Citing Articles

Current status and innovative developments of CAR-T-cell therapy for the treatment of breast cancer.

Marei H, Bedair K, Hasan A, Al-Mansoori L, Caratelli S, Sconocchia G Cancer Cell Int. 2025; 25(1):3.

PMID: 39755633 PMC: 11700463. DOI: 10.1186/s12935-024-03615-8.


Bulky glycocalyx drives cancer invasiveness by modulating substrate-specific adhesion.

Barai A, Piplani N, Saha S, Dutta S, Gomathi V, Ghogale M PNAS Nexus. 2024; 3(8):pgae335.

PMID: 39211517 PMC: 11358709. DOI: 10.1093/pnasnexus/pgae335.


CAR-T Cell Therapy for Breast Cancer: From Basic Research to Clinical Application.

Yang Y, Liu J, Lu C, Wei J Int J Biol Sci. 2022; 18(6):2609-2626.

PMID: 35414783 PMC: 8990477. DOI: 10.7150/ijbs.70120.


Overexpression of MUC1 predicts poor prognosis in patients with breast cancer.

Jing X, Liang H, Hao C, Yang X, Cui X Oncol Rep. 2018; 41(2):801-810.

PMID: 30483806 PMC: 6313072. DOI: 10.3892/or.2018.6887.


Clinical associations of mucin 1 in human lung cancer and precancerous lesions.

Saltos A, Khalil F, Smith M, Li J, Schell M, Antonia S Oncotarget. 2018; 9(86):35666-35675.

PMID: 30479696 PMC: 6235019. DOI: 10.18632/oncotarget.26278.